期刊
CELLS
卷 11, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/cells11081334
关键词
GPCR; GPR158; cancer; psychological disorders
类别
资金
- National Natural Science Foundation of China [81874176, 82072766]
- Sanming Project of Medicine in Shenzhen [SZSM201911003]
- Technology and Innovation Commission of Shenzhen [JCYJ20190809154411427, JCYJ20210324134800002, JCYJ20210324123208022]
- Research Start-up Funds of the Seventh Affiliated Hospital of Sun Yat-sen University [ZSQYRSFPD0012]
This article clarifies the origin of the evolution of GPR158 in different species, summarizes the relationship between GPR158 and different diseases for potential drug target identification, discusses recent studies on unraveling the features and principles of GPR158, and provides future perspectives.
G-protein-coupled receptors (GPCRs) remain one of the most successful targets for therapeutic drugs approved by the US Food and Drug Administration (FDA). Many novel orphan GPCRs have been identified by human genome sequencing and considered as putative targets for refractory diseases. Of note, a series of studies have been carried out involving GPCR 158 (or GPR158) since its identification in 2005, predominantly focusing on the characterization of its roles in the progression of cancer and mental illness. However, advances towards an in-depth understanding of the biological mechanism(s) involved for clinical application of GPR158 are lacking. In this paper, we clarify the origin of the GPR158 evolution in different species and summarize the relationship between GPR158 and different diseases towards potential drug target identification, through an analysis of the sequences and substructures of GPR158. Further, we discuss how recent studies set about unraveling the fundamental features and principles, followed by future perspectives and thoughts, which may lead to prospective therapies involving GPR158.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据